My research utilizes pharmacokinetic/pharmacodynamic and systems pharmacology approaches that integrates a systems perspective, mechanistic mathematical modeling and simulation with quantitative experimental lab studies to advance the discovery, development, and clinical use of drugs.
Education and Training:
Fellowship, Postdoctoral Fellow, National Cancer Institute (NCI) (2010)
PhD, Pharmaceutical Sciences, State University of New York at Buffalo (2007)
MS, Pharmacokinetics, Chungnam National University (2001)
BPharm, Pharmacy, Chungnam National University (1999)
Employment:
Adjunct Associate Professor, Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center (2020-present)
Associate Professor, Pharmaceutical Sciences, University at Buffalo School of Pharmacy (2019-present)
Associate Professor, Pharmaceutical Sciences, University of Oklahoma Health Sciences Center College of Pharmacy (2017–2019)
Investigator, Stephenson Cancer Center at OUHSC (2010–2019)
Assistant Professor, Pharmaceutical Sciences, University of Oklahoma Health Sciences Center College of Pharmacy (2010–2017)
Postdoctoral Fellow, Center for Cancer Research, National Cancer Institute, NIH (2008–2010)
Awards and Honors:
Edith Kinney Gaylord Presidential Professorship, University of Oklahoma (2019)
Research Scholar Award, American Cancer Society (2016)
Young Investigator Award in Pharmacokinetics, Pharmacodynamics, and Drug Metabolism/Clinical Pharmacology Translational Research, AAPS (2013)
Cancer Research Training Award Fellowship, Center for Cancer Research, NCI/NIH (2008)
Graduate Scholar Award in Pharmacokinetics, Pharmacodynamics, and Drug Metabolism/Clinical Pharmacology Translational Research Section, AAPS (2007)
AAPS Annual Meeting Travels Award in Pharmacokinetics, Pharmacodynamics, and Drug Metabolism (PPDM) (2006)
2006 Graduate Scholar Award, Pharmaceutical Science, University at Buffalo (2006)
Teaching Assistant Award, Pharmaceutical Sciences, University at Buffalo (2004)
Dongbu Foundation Scholarship (1997)
Research Expertise:
Anticancer drug development, ovarian cancer
Pharmacokinetics and Pharmacodynamics
Quantitative systems pharmacology (QSP) approaches: integrates a systems perspective, mechanistic mathematical modeling and simulation with quantitative experimental lab studies to advance the discovery, development, and clinical use of drugs.
siRNA therapeutics
Professional Memberships:
American Society of Clinical Pharmacology and Therapeutics (2013–present)
American Association of Cancer Research (2012–present)
International Society of Pharmacometrics (2011–present)
American Association of Pharmaceutical Scientists (2002–present)
Service Activities:
NIH; Special Emphasis Panel/Scientific Review Group ZRG1 OTC-T;; Grant Reviewer (2020–present)
Graduate Admission Committee; Member (2020–present)
American Cancer Society; Research Scholar Grant;; Grant Reviewer (2019–present)
NIH; DMP Study Section;; Grant Reviewer (2019–present)
NIH; DMP Study Section;; Grant Reviewer (2019–present)
NRG Oncology, Gynecology-Translation Committee; Member (2019–present)
Protocol Review and Monitoring Committee (PRMC); Member (2018–2019)